Ben, Xiaosong
Tian, Dan
Zhuang, Weitao
Chen, Rixin
Wang, Sichao
Zhou, Zihao
Deng, Cheng
Shi, Ruiqing
Liu, Songlin
Zhang, Dongkun
Tang, Jiming
Xie, Liang
Zhou, Haiyu
Zhang, Zhou
Li, Min
Zhang, Xuanye
Qiao, Guibin
Funding for this research was provided by:
Start-up Funding for 2019 National Natural Science Foundation of China (8197110723)
Article History
Received: 2 November 2021
Accepted: 20 September 2022
First Online: 12 October 2022
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. All patients had provided written informed consent to the research protocol approved by the institutional review board of Guangdong Provincial People’s Hospital (Ethical approval number: No.GDREC2019687H), allowing for chart review and genomic sequencing on tissue samples.
: Consent for publication has been obtained from each patient enrolled in this study.
: Zhou Zhang and Min Li are employees of Burning Rock Biotech. The other authors have no conflicts of interest to declare.